IN2015DN02576A - - Google Patents

Download PDF

Info

Publication number
IN2015DN02576A
IN2015DN02576A IN2576DEN2015A IN2015DN02576A IN 2015DN02576 A IN2015DN02576 A IN 2015DN02576A IN 2576DEN2015 A IN2576DEN2015 A IN 2576DEN2015A IN 2015DN02576 A IN2015DN02576 A IN 2015DN02576A
Authority
IN
India
Prior art keywords
materials
ldh
active
intercalated
robustness
Prior art date
Application number
Other languages
English (en)
Inventor
Claire Thompson
Cordero Marcelo Leonardo Bravo
Applicable Not
Original Assignee
Oxford Pharmascience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford Pharmascience Ltd filed Critical Oxford Pharmascience Ltd
Publication of IN2015DN02576A publication Critical patent/IN2015DN02576A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/52Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1611Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)
IN2576DEN2015 2012-10-05 2013-10-01 IN2015DN02576A (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1217911.5A GB201217911D0 (en) 2012-10-05 2012-10-05 Layered double hydroxides
PCT/GB2013/052554 WO2014053822A1 (en) 2012-10-05 2013-10-01 Layered double hydroxides

Publications (1)

Publication Number Publication Date
IN2015DN02576A true IN2015DN02576A (enExample) 2015-09-11

Family

ID=47294361

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2576DEN2015 IN2015DN02576A (enExample) 2012-10-05 2013-10-01

Country Status (16)

Country Link
US (1) US9642919B2 (enExample)
EP (2) EP2929876B1 (enExample)
JP (1) JP6363082B2 (enExample)
KR (1) KR20150063559A (enExample)
CN (1) CN104853748A (enExample)
AU (2) AU2013326298B2 (enExample)
BR (1) BR112015007529A2 (enExample)
CA (1) CA2887059A1 (enExample)
EA (1) EA034124B1 (enExample)
GB (1) GB201217911D0 (enExample)
IL (1) IL237947B (enExample)
IN (1) IN2015DN02576A (enExample)
MX (1) MX2015004188A (enExample)
PH (1) PH12015500744B1 (enExample)
WO (1) WO2014053822A1 (enExample)
ZA (2) ZA201502510B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201520762D0 (en) * 2015-11-24 2016-01-06 Isis Innovation Novel pharmaceutical compositions
JP6557597B2 (ja) * 2015-12-25 2019-08-07 共栄社化学株式会社 層状複水酸化物
JP6982080B2 (ja) 2016-09-15 2021-12-17 パリ シアンス エ レトルParis Sciences Et Lettres 層状複水酸化物の層間アニオンを交換するための方法
CN109432450B (zh) * 2018-11-23 2021-07-13 北京化工大学 一种超分子纳米化学动力药物及其在肿瘤治疗方面的应用
US12268709B2 (en) * 2019-04-19 2025-04-08 National Institute For Materials Science Nitrogenous gas sustained releasing agent and nitrogenous gas sustained releaser composed of the same as well as nitrogenous gas sustained releasing method, respiratory equipment, package, and sustained releasing apparatus using the sustained releaser
EP4228611A4 (en) * 2020-10-17 2024-11-06 Mingowood Pharmacal, LLC FORMULATION AND NON-COVALENT STABILIZATION OF OLIVETOLIC ACID DERIVATIVES
WO2025192959A1 (ko) * 2024-03-13 2025-09-18 연세대학교 산학협력단 층상형 금속 인화물 혼성체 촉매, 이의 제조방법 및 이를 구비하는 수전해 장치

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS606619A (ja) * 1983-06-27 1985-01-14 Kyowa Chem Ind Co Ltd 鉄分欠乏症処置剤及びその製法
US5079203A (en) 1990-05-25 1992-01-07 Board Of Trustees Operating Michigan State University Polyoxometalate intercalated layered double hydroxides
JP3681480B2 (ja) * 1996-09-27 2005-08-10 エーザイ株式会社 薬物の不快な味を隠蔽する組成物
GB0030460D0 (en) * 2000-12-14 2001-01-24 Isis Innovation Drug delivery system
JP4018983B2 (ja) 2000-12-19 2007-12-05 バブコック アンド ウイルコックス ボルンド エイピーエス 有害な廃棄物からオキシアニオン形成元素、特にクロムの浸出を減少させる方法
JP2004091421A (ja) * 2002-09-03 2004-03-25 Tayca Corp アスコルビン酸を取り込んだ層状複水酸化物およびそれを含む化粧料組成物
US20040138511A1 (en) 2003-01-10 2004-07-15 James Butler Aromatic alkylation process with direct recycle
AU2003902178A0 (en) 2003-05-07 2003-05-22 Commonwealth Scientific And Industrial Research Organisation Stabilization of waste material
CN1297276C (zh) 2004-06-14 2007-01-31 北京化工大学 5-氨基水杨酸插层药物缓释剂及其制备方法
US20090108233A1 (en) * 2004-12-24 2009-04-30 The Univeristy Of Queensland Preparation of suspensions
US20060140994A1 (en) 2004-12-27 2006-06-29 Bagwell Alison S Application of an antimicrobial agent on an elastomeric article
MY157620A (en) * 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
CN100462071C (zh) * 2006-09-22 2009-02-18 北京化工大学 一种磁性超分子插层结构缓释型布洛芬及其制备方法
CN101493404B (zh) 2008-01-21 2011-08-10 安徽帝元生物科技有限公司 一种化肥养分控失剂控失率的检测方法
CN101440281B (zh) * 2008-11-25 2011-11-23 北京化工大学 苯并咔唑插层水滑石复合发光材料及其制备方法
ZA201000350B (en) 2009-02-05 2010-12-29 Univ Pretoria A degradable polymeric material
CN101507819B (zh) 2009-03-27 2011-01-05 北京化工大学 一种大粒径药物插层水滑石及其制备方法
CN101597474B (zh) 2009-07-03 2012-10-17 北京化工大学 增甘磷插层结构选择性红外吸收材料及其制备方法与应用
US20110040006A1 (en) 2009-08-17 2011-02-17 Basf Se Compositions with Improved Dirt Pickup Resistance Comprising Layered Double Hydroxide Particles
CN102218043B (zh) 2011-06-14 2013-03-27 宁夏医科大学 Ldh超分子组装型阿司匹林缓释片及其制备方法

Also Published As

Publication number Publication date
EA034124B1 (ru) 2019-12-30
WO2014053822A1 (en) 2014-04-10
ZA201502510B (en) 2017-09-27
EP2929876A1 (en) 2015-10-14
EA201590673A1 (ru) 2015-08-31
JP6363082B2 (ja) 2018-07-25
EP2929876B1 (en) 2019-12-25
AU2017219016B2 (en) 2018-07-26
AU2013326298A1 (en) 2015-04-23
EP2903598A1 (en) 2015-08-12
EP2903598B1 (en) 2019-05-01
AU2017219016A1 (en) 2017-09-07
PH12015500744A1 (en) 2015-05-25
IL237947B (en) 2018-04-30
CN104853748A (zh) 2015-08-19
CA2887059A1 (en) 2014-04-10
US20150258212A1 (en) 2015-09-17
US9642919B2 (en) 2017-05-09
KR20150063559A (ko) 2015-06-09
BR112015007529A2 (pt) 2017-07-04
AU2013326298B2 (en) 2017-10-05
WO2014053822A4 (en) 2014-05-30
MX2015004188A (es) 2015-07-17
PH12015500744B1 (en) 2015-05-25
ZA201702869B (en) 2018-08-29
JP2016500667A (ja) 2016-01-14
GB201217911D0 (en) 2012-11-21

Similar Documents

Publication Publication Date Title
PH12015500744A1 (en) Layered double hydroxides
CA2830549C (en) Methods and compositions for preparing noribogaine from voacangine
EP4424408A3 (en) Processes for preparing lithium hydroxide
PH12014502704B1 (en) Compounds and compositions for modulating egfr activity
MX2021014663A (es) Il-23a y tnf-alfa orientados y compuesto y sus usos.
CA2902795C (en) Glycopyrrolate salts
MX2016016143A (es) Compuestos de [1,2,4]triazol sustituido.
AU2012265219A8 (en) Compounds containing hydrido-tricyano-borate anions
MX2017001379A (es) Producto antiseptico, proceso para prepararlo y su uso.
CA2906880C (en) Supplemented fish feed
PH12016500523B1 (en) Active compound combinations
WO2013176956A3 (en) Sintered product, metal ion adsorbent, method for removing metal ions, and metal ion removing equipment
IN2014DN04773A (enExample)
IN2014DN08412A (enExample)
MY171247A (en) Water dispersible granule, and method for producing same
WO2012017321A3 (en) Treatment for dyslipidemia
MX2015000179A (es) Composiciones y formas de dosificacion de itraconazol y metodos de uso de las mismas.
WO2014141294A3 (en) An improved process for the synthesis of melphalan and the hydrochloride salt
WO2015054712A3 (de) Cellulosesuspension, verfahren zu ihrer herstellung und verwendung
HK1215571A1 (zh) 二盐酸科比思特
WO2014057443A3 (en) Capsules of viable biomining microorganisms, with alginate and iron ions called biosigma bioleaching seeds (bbs) and their use for inoculation of these microorganisms in bioleaching processes
IN2014KN02683A (enExample)
PH12016500261A1 (en) Nanoparticles and nanoparticle composition, and method for producing nanoparticles and nanoparticle composition
EP3050575A4 (en) Disintegrating particle composition produced by two-stage wet granulation process, and intraorally disintegrating tablet containing same composition
JP2012148220A5 (enExample)